Finance

Lists
Why is SAILIFE down 3,75%?
Dive Deeper
SAILIFE:NSE
Sai Life Sciences Ltd
1 503,20 ₹
-3,75%
(-58,60) 1D
8 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SAILIFE...
Open
1 563,40 ₹
High
1 563,40 ₹
Low
1 499,00 ₹
Mkt. cap
313,71 млрд
Avg. vol.
737,90 м.
Volume
513,98 м.
P/E ratio
88,44
52-wk high
1 697,00 ₹
52-wk low
783,85 ₹
EPS
17,00 ₹
No. of employees
5 мың
Open
1 563,40 ₹
High
1 563,40 ₹
Low
1 499,00 ₹
Mkt. cap
313,71 млрд
Avg. vol.
737,90 м.
Volume
513,98 м.
P/E ratio
88,44
52-wk high
1 697,00 ₹
52-wk low
783,85 ₹
EPS
17,00 ₹
No. of employees
5 мың
News stories
From web sources and news partners
Profile
Sai Life Sciences Limited is an Indian contract research, development, and manufacturing organisation, headquartered in Hyderabad, Telangana. The company provides drug discovery, development, contract manufacturing services for small-molecule new chemical entities to pharmaceutical and biotechnology companies. The company was established in Hyderabad in January 1999 as Sai Dru Syn Laboratories Limited. It was later renamed Sai Life Sciences Limited. It operates R&D and manufacturing facilities in India, the UK, and the USA. Wikipedia
About Sai Life Sciences Ltd
CEO-
Employees5,22 мың
Founded1999
Headquarters-
Sector-
Last report
2026 ж. 07 там.
Fiscal period
Q1 2027
3,42 ₹ / 3,60 ₹
-5,00%miss
Revenue / Est. (INR)
5,54 млрд / 5,65 млрд
-1,84%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
5,37 млрд
5,56 млрд
6,02 млрд
5,54 млрд
Cost of goods sold
1,40 млрд
1,28 млрд
2,27 млрд
1,45 млрд
Cost of revenue
1,40 млрд
1,28 млрд
2,27 млрд
1,45 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,63 млрд
1,73 млрд
1,96 млрд
1,80 млрд
Operating expense
2,91 млрд
2,85 млрд
2,43 млрд
3,07 млрд
Total operating expenses
4,31 млрд
4,13 млрд
4,70 млрд
4,52 млрд
Operating income
1,06 млрд
1,44 млрд
1,32 млрд
1,02 млрд
Other non operating income
153,25 млн
83,80 млн
-333,80 млн
35,43 млн
EBT including unusual items
1,12 млрд
1,34 млрд
1,39 млрд
979,74 млн
EBT excluding unusual items
1,12 млрд
1,42 млрд
1,39 млрд
979,74 млн
Income tax expense
282,07 млн
337,91 млн
349,91 млн
246,89 млн
Effective tax rate
25,17%
25,19%
25,13%
25,20%
Other operating expenses
887,29 млн
676,72 млн
14,63 млн
814,72 млн
Net income
838,44 млн
1,00 млрд
1,04 млрд
732,85 млн
Net profit margin
15,60%
18,04%
17,31%
13,22%
Earnings per share
3,93
5,00
4,86
3,42
Interest and investment income
-
-
186,18 млн
-
Interest expense
-93,51 млн
-96,99 млн
-78,25 млн
-76,36 млн
Net interest expenses
-93,51 млн
-96,99 млн
107,93 млн
-76,36 млн
Depreciation and amortization charges
397,48 млн
440,75 млн
453,08 млн
459,37 млн
EBITDA
1,45 млрд
1,66 млрд
1,60 млрд
1,44 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары